Cargando…
Medical approach to the treatment of feline injection site sarcoma with masitinib: a case report
Feline injection site sarcoma is a common tumor among cats, for which existing medical treatments do not prove to be entirely satisfactory. In this tumor, the platelet-derived growth factor receptor, a tyrosine kinase receptor, is frequently hyperactivated. In the past, clinical case reports with im...
Autores principales: | Ledoux, Jean-Marie, Brun, Pascal, Chapuis, Tom, Dumas, Paul, Guillotin, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337170/ https://www.ncbi.nlm.nih.gov/pubmed/32670851 http://dx.doi.org/10.2147/VMRR.S67118 |
Ejemplares similares
-
Photodynamic Surgery for Feline Injection-Site Sarcoma
por: Martano, Marina, et al.
Publicado: (2019) -
The incidence of feline injection site sarcomas in the United Kingdom
por: Dean, Rachel S, et al.
Publicado: (2013) -
Current knowledge on feline injection-site sarcoma treatment
por: Zabielska-Koczywąs, Katarzyna, et al.
Publicado: (2017) -
More about masitinib
por: Walker, Ulrich A
Publicado: (2009) -
Role of nuclear factor-kappa B in feline injection site sarcoma
por: Hsueh, Cheng-Shun, et al.
Publicado: (2019)